PL376573A1 - Nowe adenowirusy, kodujące je kwasy nukleinowe i ich zastosowanie - Google Patents

Nowe adenowirusy, kodujące je kwasy nukleinowe i ich zastosowanie

Info

Publication number
PL376573A1
PL376573A1 PL376573A PL37657303A PL376573A1 PL 376573 A1 PL376573 A1 PL 376573A1 PL 376573 A PL376573 A PL 376573A PL 37657303 A PL37657303 A PL 37657303A PL 376573 A1 PL376573 A1 PL 376573A1
Authority
PL
Poland
Prior art keywords
reverse order
expressing genes
adenovirus expressing
protein
adenovirus
Prior art date
Application number
PL376573A
Other languages
English (en)
Other versions
PL219321B1 (pl
Inventor
Per Sonne Holm
Original Assignee
Per Sonne Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/005583 external-priority patent/WO2003099859A2/de
Application filed by Per Sonne Holm filed Critical Per Sonne Holm
Publication of PL376573A1 publication Critical patent/PL376573A1/pl
Publication of PL219321B1 publication Critical patent/PL219321B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Wynalazek dotyczy adenowirusów eksprymujących pierwsze białko wybrane spośród białka E1B i białka E4, przed drugim białkiem wybranym spośród białka E1A.
PL376573A 2002-10-15 2003-10-15 Adenowirus, kodujący go kwas nukleinowy, zawierający je układ replikacyjny, wektor, komórka i organizm, ich zastosowanie oraz środek farmaceutyczny PL219321B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10248039 2002-10-15
DE10322530 2003-05-19
DE10324085 2003-05-27
PCT/EP2003/005583 WO2003099859A2 (de) 2002-05-27 2003-05-27 Neue verwendung von adenoviren und dafür codierenden nukleinsäuren

Publications (2)

Publication Number Publication Date
PL376573A1 true PL376573A1 (pl) 2006-01-09
PL219321B1 PL219321B1 (pl) 2015-04-30

Family

ID=32314683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376573A PL219321B1 (pl) 2002-10-15 2003-10-15 Adenowirus, kodujący go kwas nukleinowy, zawierający je układ replikacyjny, wektor, komórka i organizm, ich zastosowanie oraz środek farmaceutyczny

Country Status (9)

Country Link
US (1) US8951772B2 (pl)
EP (1) EP1554375B1 (pl)
AU (1) AU2010257327C1 (pl)
DK (1) DK1554375T3 (pl)
MX (1) MXPA05004074A (pl)
PL (1) PL219321B1 (pl)
SG (1) SG165168A1 (pl)
WO (1) WO2004035616A2 (pl)
ZA (1) ZA200502680B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222427B8 (en) 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
US8071740B2 (en) * 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
KR100866117B1 (ko) 2001-10-19 2008-10-31 바스큘라 바이오제닉스 리미티드 혈관형성의 표적화 억제조절 및 항암 치료를 위한폴리뉴클레오타이드 작제물, 약학적 조성물 및 방법
US20060099178A1 (en) 2002-05-27 2006-05-11 Holm Per S Novel use of adenoviruses and nucleic acids coding therefor
JP2007511211A (ja) 2003-11-14 2007-05-10 ホルム，ペル・ゾンネ アデノウイルスおよびそれをコードしている核酸の新たな使用
US20090232800A1 (en) * 2004-12-31 2009-09-17 Per Sonne Holm E1-minus adenoviruses and use thereof
EP1831382B1 (en) 2004-12-31 2023-01-18 Per Sonne Holm Method for reversing multiple resistance in animal cells
KR100747646B1 (ko) * 2005-02-25 2007-08-08 연세대학교 산학협력단 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물
WO2012022496A2 (en) 2010-08-19 2012-02-23 Per Sonne Holm Method for killing tumor stem cells
CA3092907A1 (en) * 2018-03-05 2019-09-12 Klinikum Rechts Der Isar Der Technischen Universitat Munchen Treatment of tumors by a combination of an oncolytic adenovirus and a cdk4/6 inhibitor
WO2020002380A1 (en) 2018-06-25 2020-01-02 Ospedale San Raffaele S.R.L Gene therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998205A (en) * 1994-11-28 1999-12-07 Genetic Therapy, Inc. Vectors for tissue-specific replication
US6100086A (en) * 1997-04-14 2000-08-08 Genzyme Corporation Transgene expression systems
DE10015413A1 (de) * 2000-03-23 2001-09-27 Max Delbrueck Centrum Mittel zur Diagnose und Therapie viraler Erkrankungen
US6713055B2 (en) * 2000-11-27 2004-03-30 Geron Corporation Glycosyltransferase vectors for treating cancer
US20030095989A1 (en) * 2000-12-18 2003-05-22 Irving John M. Chimeric cytolytic viruses for cancer treatment
JP4361733B2 (ja) * 2000-12-28 2009-11-11 ホルム，ペル，ゾネ ウィルス核酸のインビトロにおける増幅方法及び当該増幅方法を行うことによる腫瘍細胞のインビトロにおける破壊方法
US20030138405A1 (en) * 2001-04-17 2003-07-24 Juan Fueyo Conditionally replicative adenovirus to target the Rb and Rb-related pathways

Also Published As

Publication number Publication date
ZA200502680B (en) 2005-11-30
US20060057113A1 (en) 2006-03-16
AU2010257327C1 (en) 2012-02-16
WO2004035616A2 (de) 2004-04-29
AU2010257327B2 (en) 2011-09-29
AU2010257327A1 (en) 2011-01-13
PL219321B1 (pl) 2015-04-30
EP1554375A2 (de) 2005-07-20
US8951772B2 (en) 2015-02-10
EP1554375B1 (de) 2018-08-22
SG165168A1 (en) 2010-10-28
DK1554375T3 (en) 2018-12-17
WO2004035616A3 (de) 2004-05-27
MXPA05004074A (es) 2005-09-20

Similar Documents

Publication Publication Date Title
EP1560597A4 (en) DIFFERENTIALLY EXPRESSED CANCER GENES, POLYPEPTIDES CODED THEREIN, AND METHOD OF USE THEREOF
BR0307500B1 (pt) sachÊ com trÊs soldas.
AU2001294624A1 (en) Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
PL376573A1 (pl) Nowe adenowirusy, kodujące je kwasy nukleinowe i ich zastosowanie
EP1585532A4 (en) TOPICAL INFECTION-INHIBITING FORMULATIONS
MXPA03005706A (es) Barra limpiadora de la piel con altos niveles de emoliente liquido.
BR8203013Y1 (pt) disposição em tanque agitador usado em produtos cosméticos.
ATA14882001A (de) Gewürzmühle mit doppelfunktion
ATE489401T1 (de) Pegyliertes t20-polypeptid
NO20013102L (no) Gener, proteiner og deres anvendelse
ES1053938Y (es) Unidad cosmetica.
FR2838960B1 (fr) Composition comprenant des photochromes et son utilisation en cosmetique
ITTO20010517A0 (it) Cellule progenitrici vascolari umane.
NO20013101D0 (no) Ytre overflateproteiner, deres gener og deres anvendelse
AU2003241268A1 (en) Adenoviral vector with replication-dependent transgene expression
DK1224310T3 (da) Fremstilling af rekombinante adenovira og adenovirale banker
NO20030821D0 (no) Gener og proteiner, og deres anvendelse
NO986035D0 (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i
EP1660088A4 (en) PYRIDOMORPHINANE, PYRIDAZINOMORPHINANE AND ITS USE
ITBO20030625A1 (it) "coppo con maggiore capacita' di tenuta pluviale ed eolica".
DE10045123B8 (de) Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
ITMI20022781A1 (it) Composizione per prodotti dermatologici ad azione topica e prodotti dermatologici realizzati con questa composizione.
FR2747681B1 (fr) Complexe proteique dodecaedrique adenoviral, composition le contenant et ses applications
DE10294594D2 (de) Adenovirales Vektorsystem
ITMI20022352A1 (it) Preparazioni antitumorali contenenti resveratrolo e propoli.